Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension

Background: The therapeutic benefits of β-blockers are well established in left heart failure. The Pulmonary Arterial Hypertension Treatment with Carvedilol for Heart Failure [PAHTCH] study showed safety and possible benefit of carvedilol in pulmonary arterial hypertension (PAH) associated right hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheong, Hoi I, Farha, Samar, Park, Margaret M., Thomas, James D., Saygin, Didem, Comhair, Suzy A. A., Sharp, Jacqueline, Highland, Kristin B., Tang, W. H. Wilson, Erzurum, Serpil C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299019/
https://www.ncbi.nlm.nih.gov/pubmed/30619887
http://dx.doi.org/10.3389/fcvm.2018.00180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299019/
https://www.ncbi.nlm.nih.gov/pubmed/30619887
http://dx.doi.org/10.3389/fcvm.2018.00180

Ejemplares similares